Cardiology Flashcards
Dobutamine contraindications for stress echo/ekg
Tachyarrhythmia, severe AS, HOCM, baseline severe HTN, unstable angina, large aortic aneurysm
Adenosine contraindications for stress echo/ekg
Bronchospastic airway disease, hypotension, SSS, high degree AV block
Radionuclide angiography imaging (MUGA)
Allows for accurate and seriate LVEF measurements; used to help assess cardiotoxicity from chemotherapy usually
Therapy for high risk bleeding patients who have afib AND a recent stent placement
Plavix + Xarelto/Eliquis
Do not need DAPT in these patients but can consider in patient’s with lower HASBLED scores
In CAD patients, when should you exercise caution when starting a BB?
If they are on nondihydropyridine CCVs (verapamil, diltiazem) as they may have additive negative chronotropic and inotropic effects
-Should also not use these meds w/ LV dysfunction
CCB to avoid in patients w/ refractory angina
Nifedipine; acute BP drops will cause reflex tachycardia increased myocardial O2 consumption
Med to use first when maximally dosed BB as not helped angina
CCB
Why are nitrates only used once a day?
To avoid tolerance
Drug interaction to consider when starting ranolazine
CYP inhibition (dilt and verapamil both exhibit mild inhibition)
What to monitor after administering thrombolytic for STEMI
EKG at 60 and 90 minutes
Want 50% reduction in ST segment elevation, although, 25% of patients do not achieve reperfusion
Indication for Effient
Prasugrel (P2Y inhibitor) ACS TREATED w/ PCI
-Is more potent and has quicker onset of action relative to plavix
CIs: Prior TIA or stroke (higher risk of bleeding than Plavix), age >75
Benefit of Brillinta
(Ticagrelor, P2Y inhibitor) studies have shown greater potency and faster onset of platelet inhibition
PLATO trial: Significantly lower mortality rates compared to Plavix
ADR: Dyspnea
Antiplatelet therapy for ACS
At least one year of DAPT if patient has low bleed risk
DM medication that has reduced risk of cardiovascular death
Trulicity (liraglutide) : GLP-1 agonist
Type of shock needed to treat afib w/ hemodynamic compromise
R-R wave synchronized shock
CHADS VASC score needed for valvular afib
0
You always anticoagulate valvular afib
Valvular afib refers to mitral stenosis, rheumatic mitral valve disease, or mechanical heart valve NOT MVR
Duration of anticoagulation needed prior to cardioversion for afib
At least 3 weeks (assuming they have been in afib for >48hrs)
Then receive anticoagulation for four weeks after procedure
Indications for permanent pacemaker in symptomatic bradycardia
- No reversible cause
- Significant pauses (>3 seconds)
- HR <40
- A fib w/ pause of >5 seconds
- Alternating bundle branch block
- Mobitz type II or complete heart block
Capabilities of implantable cardioverter-defibrillator
Monitors and treats ventricular arrhythmias
- Pacemaker present
- Can also do antitachycardia management and defibrillate
Subcutaneous implantable cardioverter-defibrillator capabilities
Monitors and treats ventricular arrhythmias ONLY
Inappropriate sinus tachycardia
Baseline tachycardia w/ exaggerated increases w/ minor physical activity; usually has normal HR during sleep
Commonly in female health professionals
Can treat symptoms w/ BB, CCBs, ivabradine if needed
Class 1A antiarrhythmics
Disopyramidine
Quinidine
Procainimide
- Decreases speed of depolarization and prolongs repolarization
- Used for preexcitable afib, Brugada syndrome, afib, SVT, ventricular arryhthmias
ADR: Drug induced lupus w/ procainamide
CIs to Class 1A antiarrhythmics
Ischemic Heart Disease Structural Heart Disease Third degree AV block w/o pacemaker Prolonged QT ESRD
**Associated w/ increased mortality in these patients
Class Ib antiarrhythmics
Lidocaine
Mexiletine
Decreases speed of depolarization
Used for ventricular arrhythmias ONLY
ADR: HA, dizziness
CI: Liver disease
Class IC antiarrhythmics
Fleicainide
Propafenone
Decreases speed of depolarization and repolarization
Used for afib, SVT, ventricular arrhythmias
ADRs: HA, dizziness, neurologic symptoms
Contraindications to Class IC antiarrhythmics
Ischemic Heart Disease Structural Heart Disease Sinus node dysfunction 2nd or higher AV block Bundle branch disease w/o pacemaker
Class III antiarrhythmics
Sotalol, dofetilide
Prolongs the action potential by blocking K channels
Used for rate control of atrial and ventricular arrhythmias
ADRs: HA, dizziness, bradycardia, dyspnea w/ sotalol, torsades w/ dofetilide
Amiodarone info
Works through multiple mechanisms although primarily works by extending repolarization
Used for atrial and ventricular arrhythmias
CIs: Advanced liver, lung, or thyroid disease
Monitor labs q6 months and consider PFTs
Primary use of Class II (BBs) and Class IV (CCBs) antiarrhythmics
Inhibit AV conduction in supraventricular tachyarrhythmias or atrial arrhythmias
Pradaxa
Dabigatran (direct thrombin inhibitor); advantage to this is Idaracuizumab exists and can reverse effects